Observational studyJournal of robotic surgery2026
Feasibility and clinical outcomes of same-day discharge after robot-assisted partial nephrectomy at an ambulatory surgery center.
Observational study in Journal of robotic surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
- Erratum issued
Authors and funding
15 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Robot-assisted partial nephrectomy (RAPN) enables the management of complex localized renal masses while preserving renal function. However, the adoption of institutionalized same-day discharge (SDD) pathways remains limited. Herein, we report the safety and feasibility of SDD RAPN at an ambulatory surgery center (ASC) at our institution. We performed a retrospective observational study of patients who underwent SDD RAPN at a freestanding ASC at our institution during 2022-2025. Patients were eligible for the SDD pathway if they had a good performance status (ECOG 0-1), localized renal masses amenable to partial resection, reliable post-discharge communication, and travel time < 2 h from their residence to the hospital. A total of 63 patients underwent 65 SDD RAPNs at our ASC during 2022-2025. Patients had a median age at surgery of 62 years (interquartile range 51-71 years), and most were male (73%), non-Hispanic (63%), White (70%), and overweight (54%). Most patients had an American Society of Anesthesiologists score of III (60%), were never-smokers (63%), and had clinical stage T1 disease (92%). Most procedures were for lesions of moderate complexity (46%). All surgical specimens revealed negative surgical margins (100%), with the most common histology being clear cell carcinoma (63%). Overall, 4/65 (6%) procedures led to any-grade Clavien-Dindo complications and 2/65 (3%) required readmissions. No deaths or local or distant recurrence were observed at a median follow-up of 1.1 years. Overall, we found that SDD is safe and feasible for appropriately selected patients undergoing RAPN, with promising perioperative outcomes and low morbidity rates.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.